Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death

Area of Science:

• Cell Biology
• Cancer Biology
• Genetics

Background:

• Disrupted mitosis leads to chromosome missegregation and aneuploidy.
• Aneuploidy is a common feature of cancer cells and a potential driver of tumorigenesis.
• Antimitotic drugs targeting spindle assembly are used in cancer therapy, causing mitotic arrest via checkpoint activation.

Purpose of the Study:

• To review the intricate connections between the mitotic checkpoint, aneuploidy, and cellular responses to antimitotic drugs.
• To elucidate the mechanisms of adaptation to prolonged mitotic arrest.
• To understand the pathways leading to antimitotic drug-induced cell death.

Main Methods:

• Literature review of studies on mitotic checkpoint, aneuploidy, and cancer therapy.
• Analysis of mechanisms underlying adaptation to mitotic arrest.
• Examination of cell death pathways activated by antimitotic agents.

Main Results:

• The mitotic checkpoint plays a critical role in preventing aneuploidy.
• Cancer cells can adapt to sustained mitotic arrest, potentially contributing to drug resistance.
• Adaptation pathways influence the ultimate fate of cells, determining survival or death.

Conclusions:

• Understanding the interplay between the mitotic checkpoint, aneuploidy, and adaptation is crucial for improving cancer treatments.
• Targeting adaptation mechanisms may offer novel therapeutic strategies against aneuploid cancers.
• The balance between mitotic arrest, adaptation, and cell death is a key determinant of antimitotic drug efficacy.